158 related articles for article (PubMed ID: 37697432)
1. Research trends on the relationship between Helicobacter pylori and microbiota: A bibliometric analysis.
Li Y; Ouyang Y; He C
Helicobacter; 2023 Dec; 28(6):e13021. PubMed ID: 37697432
[TBL] [Abstract][Full Text] [Related]
2. States and hotspots in Helicobacter pylori research from 2002 to 2021: A bibliometric analysis.
Wang R; Huang S; Gan P; Pan X; Wang P; Zhong X; Lü M; Zhou X; Tang X
Helicobacter; 2023 Aug; 28(4):e12986. PubMed ID: 37133423
[TBL] [Abstract][Full Text] [Related]
3. Probiotics modulate gastrointestinal microbiota after
He C; Xie Y; Zhu Y; Zhuang K; Huo L; Yu Y; Guo Q; Shu X; Xiong Z; Zhang Z; Lyu B; Lu N
Front Immunol; 2022; 13():1033063. PubMed ID: 36426355
[TBL] [Abstract][Full Text] [Related]
4. Research Trends on Clinical Helicobacter pylori Eradication: A Bibliometric Analysis from 1983 to 2020.
Ouyang Y; Zhu Z; Huang L; Zeng C; Zhang L; Wu WK; Lu N; Xie C
Helicobacter; 2021 Oct; 26(5):e12835. PubMed ID: 34258827
[TBL] [Abstract][Full Text] [Related]
5. Bibliometric analysis of Helicobacter pylori resistance-from 2002 to 2022.
Li M; Gao N; Wang S; Guo Y; Liu Z
Helicobacter; 2023 Aug; 28(4):e12983. PubMed ID: 37102470
[TBL] [Abstract][Full Text] [Related]
6. Research trends on the relationship between Microbiota and Gastric Cancer: A Bibliometric Analysis from 2000 to 2019.
Zhang T; Yin X; Yang X; Man J; He Q; Wu Q; Lu M
J Cancer; 2020; 11(16):4823-4831. PubMed ID: 32626529
[No Abstract] [Full Text] [Related]
7. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
[TBL] [Abstract][Full Text] [Related]
8. Effect of
Guo Y; Cao XS; Guo GY; Zhou MG; Yu B
Front Cell Infect Microbiol; 2022; 12():899248. PubMed ID: 35601105
[TBL] [Abstract][Full Text] [Related]
9. Research trends on the relationship between gut microbiota and colorectal cancer: A bibliometric analysis.
Wu W; Ouyang Y; Zheng P; Xu X; He C; Xie C; Hong J; Lu N; Zhu Y; Li N
Front Cell Infect Microbiol; 2022; 12():1027448. PubMed ID: 36699721
[TBL] [Abstract][Full Text] [Related]
10. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
Liou JM; Jiang XT; Chen CC; Luo JC; Bair MJ; Chen PY; Chou CK; Fang YJ; Chen MJ; Chen CC; Lee JY; Yang TH; Yu CC; Kuo CC; Chiu MC; Chen CY; Shun CT; Hu WH; Tsai MH; Hsu YC; Tseng CH; Chang CY; Lin JT; El-Omar EM; Wu MS;
Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):228-241. PubMed ID: 36549320
[TBL] [Abstract][Full Text] [Related]
11. Research on antibiotic resistance in
Yuan C; Yu C; Sun Q; Xiong M; Zhou S; Zeng M; Song H
Front Microbiol; 2023; 14():1208157. PubMed ID: 37389333
[TBL] [Abstract][Full Text] [Related]
12. Bibliometric analysis of pancreatic diseases and gut microbiota research from 2002 to 2022.
Li X; Li Y; He C; Zhu Y
Heliyon; 2024 Jan; 10(1):e23483. PubMed ID: 38187305
[TBL] [Abstract][Full Text] [Related]
13. Global knowledge mapping and emerging trends in Helicobacter pylori-related precancerous lesions of gastric cancer research: A bibliometric analysis from 2013 to 2023.
Xiong M; Yu C; Ren B; Zhong M; Peng Q; Zeng M; Song H
Medicine (Baltimore); 2023 Dec; 102(48):e36445. PubMed ID: 38050286
[TBL] [Abstract][Full Text] [Related]
14. Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children.
Zhou Y; Ye Z; Wang Y; Huang Z; Zheng C; Shi J; Tang W; Zhang P; Wang S; Huang Y
Helicobacter; 2021 Aug; 26(4):e12809. PubMed ID: 33899288
[TBL] [Abstract][Full Text] [Related]
15. The impact of Helicobacter pylori infection and eradication therapy containing minocycline and metronidazole on intestinal microbiota.
Cui MY; Cui ZY; Zhao MQ; Zhang MJ; Jiang QL; Wang JJ; Lu LG; Lu YY
BMC Microbiol; 2022 Dec; 22(1):321. PubMed ID: 36581836
[TBL] [Abstract][Full Text] [Related]
16. Trends in
Yu C; Qiu J; Xiong M; Ou C; Zeng M; Song H
Front Med (Lausanne); 2022; 9():1027534. PubMed ID: 36507534
[TBL] [Abstract][Full Text] [Related]
17. The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults.
Yuan Z; Xiao S; Li S; Suo B; Wang Y; Meng L; Liu Z; Yin Z; Xue Y; Zhou L
Helicobacter; 2021 Dec; 26(6):e12848. PubMed ID: 34448282
[TBL] [Abstract][Full Text] [Related]
18. Probiotics mitigate Helicobacter pylori-induced gastric inflammation and premalignant lesions in INS-GAS mice with the modulation of gastrointestinal microbiota.
He C; Peng C; Xu X; Li N; Ouyang Y; Zhu Y; Lu N
Helicobacter; 2022 Aug; 27(4):e12898. PubMed ID: 35531615
[TBL] [Abstract][Full Text] [Related]
19. Global status and trends of gastric cancer and gastric microbiota research: a bibliometric analysis.
Ke Y; Tan C; Zhen J; Dong W
Front Microbiol; 2024; 15():1341012. PubMed ID: 38655079
[TBL] [Abstract][Full Text] [Related]
20. Effects of probiotics on gastric microbiota and its precombination with quadruple regimen for Helicobacter pylori eradication.
Wu Y; Dong XY; Zhou XZ; Li ZS; Du YQ
J Dig Dis; 2022 Aug; 23(8-9):462-472. PubMed ID: 36208049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
